Clinical Trials Logo

Clinical Trial Summary

To evaluate the possibility to properly discriminate between healthy bladder tissue and BCa with a multimodal fiber optic spectroscopy (MFOS) technique, in order to possibly introduce a more objective way to detect BCa, thus reducing inter-observer variability and maybe to determine urothelial carcinoma stage and grade with a comparable accuracy, specificity and sensibility of the current gold standard histopathological analysis


Clinical Trial Description

Observational single center study on human biological samples to evaluate the possibility to discriminate between healthy and tumor tissue on urothelial bladder samples. Aim of the study is to provide a fast, reliable and label free aid/alternative to current histopathology ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04310813
Study type Observational
Source Careggi Hospital
Contact
Status Completed
Phase
Start date November 1, 2016
Completion date March 1, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04081246 - Transurethral Modified En Bloc Resection For Large Bladder Tumours. N/A
Recruiting NCT03331705 - Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures N/A
Completed NCT01750970 - Endoscopic Resection of Bladder Tumors N/A
Unknown status NCT01826565 - Comparison of Two Insertion Technique of I-gel N/A
Completed NCT01665586 - Effective Dose of Dexmedetomidine for Sedation in Patients Undergoing TURP/TURB Under Spinal Anesthesia With or Without Fentanyl by Age Groups: Randomized Comparative Study N/A
Recruiting NCT03221829 - A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients N/A
Recruiting NCT05872451 - Current Intensity for the Obturator Nerve Block N/A
Recruiting NCT03029676 - The Assessment of POCD After TURBT Under Spinal Anesthesia Phase 4
Completed NCT04209114 - A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer Phase 3
Recruiting NCT04638569 - Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs N/A
Recruiting NCT06033040 - Medical Imaging in Bladder Tumors by MRI
Withdrawn NCT03517995 - Randomized, Phase II Clinical Trial of Sulforaphane in Bladder Cancer Chemoprevention Phase 2